Literature DB >> 16267879

Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study.

Tuhina Neogi1, David J Hunter, Christine E Chaisson, Donald Allensworth-Davies, Yuqing Zhang.   

Abstract

OBJECTIVE: To evaluate the patterns and determinants of medication use during recurrent gout attacks.
METHODS: We followed participants with documented gout in an online prospective case-crossover study. During an attack, subjects were asked if they had consulted a physician for the attack and what medications they were using. Definitely inappropriate therapy was defined as use of allopurinol or a uricosuric agent acutely without having used it as a prophylactic. Potentially inappropriate therapy was defined as use of analgesics alone, alternative remedies, or no medications. We estimated the risk of having >or= 1 attack in 1 year using life table methods. We examined the relation of various risk factors to the risk of inappropriate therapy using Poisson regression.
RESULTS: Among 232 participants (mean age 52 yrs, 81% male) with documented gout, the risk of having >or= 1 attack in a year was 69%. One hundred ten participants consulted a physician for each attack, 49 did so for only some attacks, while 43 never consulted a physician for any attack. Fifty-three participants had definitely (n = 10) or potentially (n = 43) inappropriate therapy for their recurrent attacks. Physician consultation for an attack was associated with increased risk of inappropriate therapy (risk ratio, RR, 2.5, p = 0.006), whereas an increasing number of gout attacks was associated with lower risk of inappropriate therapy (RR 0.8, p = 0.01).
CONCLUSION: Given the high risk of recurrent attacks and the substantial number of persons whose attacks are not appropriately managed, further education about management of gout attacks for both patients and physicians may be warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16267879

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  45 in total

1.  Quality of care in patients with gout: why is management suboptimal and what can be done about it?

Authors:  N Lawrence Edwards
Journal:  Curr Rheumatol Rep       Date:  2011-04       Impact factor: 4.592

2.  Purine-rich foods intake and recurrent gout attacks.

Authors:  Yuqing Zhang; Clara Chen; Hyon Choi; Christine Chaisson; David Hunter; Jingbo Niu; Tuhina Neogi
Journal:  Ann Rheum Dis       Date:  2012-05-30       Impact factor: 19.103

3.  Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis.

Authors:  Eric Jutkowitz; Fernando Alarid-Escudero; Hyon K Choi; Karen M Kuntz; Hawre Jalal
Journal:  Pharmacoeconomics       Date:  2017-10       Impact factor: 4.981

4.  Quality of care for gout in the US needs improvement.

Authors:  Jasvinder A Singh; James S Hodges; John P Toscano; Steven M Asch
Journal:  Arthritis Rheum       Date:  2007-06-15

Review 5.  Why is gout so poorly managed?

Authors:  Eliseo Pascual; Francisca Sivera
Journal:  Ann Rheum Dis       Date:  2007-10       Impact factor: 19.103

6.  Patients and providers view gout differently: a qualitative study.

Authors:  Leslie R Harrold; Kathleen M Mazor; Sarah Velten; Ira S Ockene; Robert A Yood
Journal:  Chronic Illn       Date:  2010-07-30

7.  Factors associated with gout in South Koreans: analysis using the National Health Insurance Corporation and the National Health Screening Exam databases.

Authors:  Chan Hee Lee; Na Young Sung; Jisoo Lee; Sang-Cheol Bae
Journal:  Clin Rheumatol       Date:  2013-02-10       Impact factor: 2.980

8.  Impact of deficits in gout care on hospitalizations.

Authors:  Prachaya Nitichaikulvatana; Katherine S Upchurch; Leslie R Harrold
Journal:  J Clin Rheumatol       Date:  2011-10       Impact factor: 3.517

Review 9.  Quality of life and quality of care for patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

Review 10.  Gout. Novel therapies for treatment of gout and hyperuricemia.

Authors:  Robert Terkeltaub
Journal:  Arthritis Res Ther       Date:  2009-07-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.